There are two sides to every coin. For penny stocks, or tickers that trade for less than $5 per share, this rings especially …
Shares in Otonomy, Inc. (OTIC) spiked 15% in pre-market trading after the biotech company disclosed statistical data on its vertigo drug Otividex and …
OTIC stock fired to the roof after successful late-trial results in Meniere’s; Edward Nash cheers.
It’s a very rewarding trading day for investors in Otonomy Inc (NASDAQ:OTIC) with shares up over 80%, making the stock Wall Street’s bull …
A glimpse into OrbiMed Advisors’ recent moves in the healthcare space.
How Do Biotech’s Movers and Shakers Fare Under Puravida Funds’ Healthcare-Centric Trading Strategy?
Edward Nash Sees Otonomy as a Pure Speculative Pharma Play
Hedge Fund Guru Mark Kingdon Isn’t Taking Any Risks with OTIC, SGYP, ATRS
Wednesday turned out to be a nightmare for Otonomy Inc (NASDAQ:OTIC) investors, after the drug maker announced disappointing results from a pivotal Phase …
